Implementation, target population, compliance and barriers to risk guided therapy.

Item

http://www.wikidata.org/entity/Q38026703

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Implementation, target population, compliance and barriers to risk guided therapy.

@en

type

Item

label

Implementation, target population, compliance and barriers to risk guided therapy.

@en

prefLabel

Implementation, target population, compliance and barriers to risk guided therapy.

@en

P1476

Implementation, target population, compliance and barriers to risk guided therapy.

@en

P2093

Eric Bruckert

http://www.w3.org/2001/XMLSchema#string

Lale Tokgozoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness of weight-loss interventions in clinical practice

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study.

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute

Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.

Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: systematic review.

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey.

P304

37-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2047487312448989

http://www.w3.org/2001/XMLSchema#string

P433

2 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22801069

http://www.w3.org/2001/XMLSchema#string